Production (Stage)
SurgLine International, Inc.
SGLN
$0.00
$0.000.00%
OTC PK
07/31/2012 | 04/30/2012 | ||||
---|---|---|---|---|---|
Net Income | 84.27% | -- | |||
Total Depreciation and Amortization | -- | -- | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | -91.08% | -- | |||
Change in Net Operating Assets | -10.63% | -- | |||
Cash from Operations | 93.24% | -- | |||
Capital Expenditure | 182.35% | -- | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | -- | -- | |||
Cash from Investing | 182.35% | -- | |||
Total Debt Issued | 147.75% | -- | |||
Total Debt Repaid | 100.00% | -- | |||
Issuance of Common Stock | -100.00% | -- | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | -- | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -- | -- | |||
Cash from Financing | -96.00% | -- | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | -106.67% | -- | |||